Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Paraoxonase Has a Major Role in the Hydrolysis of Prulifloxacin (NM441), a Prodrug of a New Antibacterial Agent

Katsuhiko Tougou, Akio Nakamura, Shuji Watanabe, Yoshio Okuyama and Akira Morino
Drug Metabolism and Disposition April 1998, 26 (4) 355-359;
Katsuhiko Tougou
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Akio Nakamura
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shuji Watanabe
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yoshio Okuyama
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Akira Morino
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 26 no. 4 355-359
PubMed 
9531524

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received August 25, 1997
  • Accepted December 5, 1997
  • Published online April 1, 1998.

Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Katsuhiko Tougou,
  2. Akio Nakamura,
  3. Shuji Watanabe,
  4. Yoshio Okuyama and
  5. Akira Morino
  1. Research Laboratories, Nippon Shinyaku Co.
    View Full Text

    Statistics from Altmetric.com

    Article usage

    Article usage: August 2017 to August 2022

    AbstractFullPdf
    Aug 20172125
    Sep 20171132
    Oct 20172109
    Nov 20177346
    Dec 20170101
    Jan 2018070
    Feb 2018083
    Mar 20183226
    Apr 20180183
    May 20182183
    Jun 20180226
    Jul 20182123
    Aug 2018077
    Sep 20180114
    Oct 20180176
    Nov 2018183
    Dec 20181832
    Jan 2019200
    Feb 2019832
    Mar 20191220
    Apr 2019600
    May 20191711
    Jun 2019913
    Jul 2019521
    Aug 20192133
    Oct 20191251
    Nov 20191901
    Dec 20192030
    Jan 20201600
    Feb 20201412
    Mar 20204024
    May 20201500
    Jun 2020910
    Jul 20201000
    Aug 2020344
    Sep 20201003
    Oct 20202400
    Nov 20201010
    Dec 20203054
    Jan 20211771
    Feb 2021940
    Mar 20213225
    Apr 20212440
    May 20212148
    Jun 20211221
    Jul 20211542
    Aug 20212431
    Sep 20211832
    Oct 20211410
    Nov 20212922
    Dec 20212441
    Jan 2022510
    Feb 20222451
    Mar 2022773
    Apr 202236103
    May 20222072
    Jun 20221421
    Jul 20224031
    Aug 2022810

    PreviousNext
    Back to top

    In this issue

    Drug Metabolism and Disposition
    Vol. 26, Issue 4
    1 Apr 1998
    • Table of Contents
    • Index by author
    Download PDF
    Article Alerts
    Sign In to Email Alerts with your Email Address
    Email Article

    Thank you for sharing this Drug Metabolism & Disposition article.

    NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

    Enter multiple addresses on separate lines or separate them with commas.
    Paraoxonase Has a Major Role in the Hydrolysis of Prulifloxacin (NM441), a Prodrug of a New Antibacterial Agent
    (Your Name) has forwarded a page to you from Drug Metabolism & Disposition
    (Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Citation Tools
    Research ArticleArticle

    Paraoxonase Has a Major Role in the Hydrolysis of Prulifloxacin (NM441), a Prodrug of a New Antibacterial Agent

    Katsuhiko Tougou, Akio Nakamura, Shuji Watanabe, Yoshio Okuyama and Akira Morino
    Drug Metabolism and Disposition April 1, 1998, 26 (4) 355-359;

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero

    Share
    Research ArticleArticle

    Paraoxonase Has a Major Role in the Hydrolysis of Prulifloxacin (NM441), a Prodrug of a New Antibacterial Agent

    Katsuhiko Tougou, Akio Nakamura, Shuji Watanabe, Yoshio Okuyama and Akira Morino
    Drug Metabolism and Disposition April 1, 1998, 26 (4) 355-359;
    del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Jump to section

    • Article
      • Abstract
      • Materials and Methods
      • Results
      • Discussion
      • Footnotes
      • References
    • Figures & Data
    • Info & Metrics
    • eLetters
    • PDF

    Related Articles

    Cited By...

    More in this TOC Section

    • Human ADME Properties of Abrocitinib
    • MSCs Pharmacokinetics under liver diseases
    • In Vitro P450 Suppression by Peptide Not Observed in Clinic
    Show more Article

    Similar Articles

    Advertisement
    • Home
    • Alerts
    Facebook   Twitter   LinkedIn   RSS

    Navigate

    • Current Issue
    • Fast Forward by date
    • Fast Forward by section
    • Latest Articles
    • Archive
    • Search for Articles
    • Feedback
    • ASPET

    More Information

    • About DMD
    • Editorial Board
    • Instructions to Authors
    • Submit a Manuscript
    • Customized Alerts
    • RSS Feeds
    • Subscriptions
    • Permissions
    • Terms & Conditions of Use

    ASPET's Other Journals

    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    ISSN 1521-009X (Online)

    Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics